Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Bell

Showing results (41-50 of 105) with videos related to

Pageof 11
Sort By:
Molecular Therapy. Methods & Clinical Development|August 4, 2018
Toxicology Study of Intra-Cisterna Magna Adeno-Associated Virus 9 Expressing Iduronate-2-Sulfatase in Rhesus MacaquesJuliette Hordeaux, Christian Hinderer, Tamara Goode, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 6, 2009
Adeno-associated virus capsid structure drives CD4-dependent CD8+ T cell response to vector encoded proteinsLauren E Mays, Luk H Vandenberghe, Ru Xiao, et al.
Journal of Virology|May 18, 2023
Vector Affinity and Receptor Distribution Define Tissue-Specific Targeting in an Engineered AAV CapsidR Alexander Martino, Qiang Wang, Hao Xu, et al.
Molecular Genetics and Metabolism|March 12, 2017
AAV gene therapy corrects OTC deficiency and prevents liver fibrosis in aged OTC-knock out heterozygous miceLili Wang, Peter Bell, Hiroki Morizono, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 13, 2005
Biology of AAV serotype vectors in liver-directed gene transfer to nonhuman primatesGuangping Gao, You Lu, Roberto Calcedo, et al.
Plos One|February 6, 2013
AAV9 targets cone photoreceptors in the nonhuman primate retinaLuk H Vandenberghe, Peter Bell, Albert M Maguire, et al.
Molecular Genetics and Metabolism|December 3, 2011
Preclinical evaluation of a clinical candidate AAV8 vector for ornithine transcarbamylase (OTC) deficiency reveals functional enzyme from each persisting vector genomeLili Wang, Hiroki Morizono, Jianping Lin, et al.
Molecular Therapy. Methods & Clinical Development|August 4, 2018
Toxicology Study of Intra-Cisterna Magna Adeno-Associated Virus 9 Expressing Human Alpha-L-Iduronidase in Rhesus MacaquesJuliette Hordeaux, Christian Hinderer, Tamara Goode, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 29, 2015
Comparative Study of Liver Gene Transfer With AAV Vectors Based on Natural and Engineered AAV CapsidsLili Wang, Peter Bell, Suryanarayan Somanathan, et al.
Nucleic Acids Research|December 6, 2002
Predicting the success of primer extension genotyping assays using statistical modelingAnton Yuryev, JianPing Huang, Mark Pohl, et al.
Pageof 11

Showing results (41-50 of 105) with videos related to

Sort By:
Pageof 11
Molecular Therapy. Methods & Clinical Development|August 4, 2018
Toxicology Study of Intra-Cisterna Magna Adeno-Associated Virus 9 Expressing Iduronate-2-Sulfatase in Rhesus MacaquesJuliette Hordeaux, Christian Hinderer, Tamara Goode, et al.
Journal of Immunology (Baltimore, Md. : 1950)|May 6, 2009
Adeno-associated virus capsid structure drives CD4-dependent CD8+ T cell response to vector encoded proteinsLauren E Mays, Luk H Vandenberghe, Ru Xiao, et al.
Journal of Virology|May 18, 2023
Vector Affinity and Receptor Distribution Define Tissue-Specific Targeting in an Engineered AAV CapsidR Alexander Martino, Qiang Wang, Hao Xu, et al.
Molecular Genetics and Metabolism|March 12, 2017
AAV gene therapy corrects OTC deficiency and prevents liver fibrosis in aged OTC-knock out heterozygous miceLili Wang, Peter Bell, Hiroki Morizono, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|October 13, 2005
Biology of AAV serotype vectors in liver-directed gene transfer to nonhuman primatesGuangping Gao, You Lu, Roberto Calcedo, et al.
Plos One|February 6, 2013
AAV9 targets cone photoreceptors in the nonhuman primate retinaLuk H Vandenberghe, Peter Bell, Albert M Maguire, et al.
Molecular Genetics and Metabolism|December 3, 2011
Preclinical evaluation of a clinical candidate AAV8 vector for ornithine transcarbamylase (OTC) deficiency reveals functional enzyme from each persisting vector genomeLili Wang, Hiroki Morizono, Jianping Lin, et al.
Molecular Therapy. Methods & Clinical Development|August 4, 2018
Toxicology Study of Intra-Cisterna Magna Adeno-Associated Virus 9 Expressing Human Alpha-L-Iduronidase in Rhesus MacaquesJuliette Hordeaux, Christian Hinderer, Tamara Goode, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|September 29, 2015
Comparative Study of Liver Gene Transfer With AAV Vectors Based on Natural and Engineered AAV CapsidsLili Wang, Peter Bell, Suryanarayan Somanathan, et al.
Nucleic Acids Research|December 6, 2002
Predicting the success of primer extension genotyping assays using statistical modelingAnton Yuryev, JianPing Huang, Mark Pohl, et al.
Pageof 11